2017
DOI: 10.1021/acs.nanolett.6b04261
|View full text |Cite
|
Sign up to set email alerts
|

Cancer-Microenvironment-Sensitive Activatable Quantum Dot Probe in the Second Near-Infrared Window

Abstract: Recent technological advances have expanded fluorescence (FL) imaging into the second near-infrared region (NIR-II; wavelength = 1000-1700 nm), providing high spatial resolution through deep tissues. However, bright and compact fluorophores are rare in this region, and sophisticated control over NIR-II probes has not been fully achieved yet. Herein, we report an enzyme-activatable NIR-II probe that exhibits FL upon matrix metalloprotease activity in tumor microenvironment. Bright and stable PbS/CdS/ZnS core/sh… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
78
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 94 publications
(78 citation statements)
references
References 41 publications
0
78
0
Order By: Relevance
“…The parallel development of improved detectors, 3D deconvolution, spectral unmixing, and reconstruction algorithms will also aid in the adoption of QDs for deeper tissue imaging using fluorescence‐mediated tomography. Long‐term, QD may also serve additional roles such as probes for multiplexed characterization of the tumor microenvironment, targeted drug delivery, photodynamic therapy, or photothermal therapy . Ultimately, the goals of QD design should be to avoid adverse reactions, demonstrate a high preference for tumors or lymph nodes compared to healthy tissue, exhibit strong and stable fluorescence within the near‐infrared biological imaging windows, and be cleared by the body over a duration that is sufficiently long to retain optimal contrast during surgery, but then be completely cleared soon after.…”
Section: Resultsmentioning
confidence: 99%
“…The parallel development of improved detectors, 3D deconvolution, spectral unmixing, and reconstruction algorithms will also aid in the adoption of QDs for deeper tissue imaging using fluorescence‐mediated tomography. Long‐term, QD may also serve additional roles such as probes for multiplexed characterization of the tumor microenvironment, targeted drug delivery, photodynamic therapy, or photothermal therapy . Ultimately, the goals of QD design should be to avoid adverse reactions, demonstrate a high preference for tumors or lymph nodes compared to healthy tissue, exhibit strong and stable fluorescence within the near‐infrared biological imaging windows, and be cleared by the body over a duration that is sufficiently long to retain optimal contrast during surgery, but then be completely cleared soon after.…”
Section: Resultsmentioning
confidence: 99%
“…The NIR‐II QDs, which were composed of bright and stable PbS/CdS/ZnS (core/shell/shell) that emit at 1200 nm, have been demonstrated selective imaging at tumor sites by using a colon cancer mouse model. Further optical phantom experiments confirmed the advantages of the NIR‐II QDs over conventional dyes in the first NIR region …”
Section: Biomedical Applications Of Nir Qdsmentioning
confidence: 70%
“…The high activity of matrix metalloproteinase (MMP) is known as a hallmark of the cancer microenvironment. [ 64,86,87 ] Recently, Kim and colleagues reported an MMP‐activatable NIR‐II quantum dots (QDs) for tumor detection ( Figure a–d). [ 64 ] In this study, the authors synthesized PbS/CdS/ZnS core/shell/shell QDs with NIR‐II emission.…”
Section: Advanced Nir Light For Cell Function Imagingmentioning
confidence: 99%